Hamman-Rich syndrome pathophysiology: Difference between revisions

Jump to navigation Jump to search
Chandrakala Yannam (talk | contribs)
No edit summary
Chandrakala Yannam (talk | contribs)
No edit summary
Line 2: Line 2:
__NOTOC__
__NOTOC__


{{CMG}}; {{AE}}  
{{CMG}}; {{AE}} {{CK}}


==Overview==
==Overview==
The exact pathogenesis of [disease name] is not fully understood.
Acute interstitial pneumonitis show histopathologic appearance of diffuse alveolar damage, that is idiopathic. On gross examination, lungs appear firm, heavy and have a dark red or beefy appearance and show irregular areas of consolidation and fibrosis.  


OR


It is thought that [disease name] is the result of / is mediated by / is produced by / is caused by either [hypothesis 1], [hypothesis 2], or [hypothesis 3].
OR
[Pathogen name] is usually transmitted via the [transmission route] route to the human host.
OR
Following transmission/ingestion, the [pathogen] uses the [entry site] to invade the [cell name] cell.
OR
[Disease or malignancy name] arises from [cell name]s, which are [cell type] cells that are normally involved in [function of cells].
OR
The progression to [disease name] usually involves the [molecular pathway].
OR
The pathophysiology of [disease/malignancy] depends on the histological subtype.


==Pathophysiology==
==Pathophysiology==
Line 63: Line 40:
**[[Hyaline]] membrane formation
**[[Hyaline]] membrane formation
**[[Interstitial lung disease|Interstitial fibrosis]]:
**[[Interstitial lung disease|Interstitial fibrosis]]:
***It is [[diffuse]], [[Uniform distribution|uniform]] temporally with extensive [[Fibroblast|fibroblastic]] and [[Myofibroblast|myofibroblastic]] proliferation and relatively less [[collagen]] deposition.
***It is [[diffuse]], bilateral, [[Uniform distribution|uniform]] temporally with extensive [[Fibroblast|fibroblastic]] and [[Myofibroblast|myofibroblastic]] proliferation and relatively less [[collagen]] deposition.
***The [[Uniform distribution|uniformity]] of the [[Fibroblast|fibroblastic]]/[[Myofibroblast|myofibroblastic]] proliferation and prominent activity distinguish AIP from the other types of idiopathic interstitial pneumonia.
***The [[Uniform distribution|uniformity]] of the [[Fibroblast|fibroblastic]]/[[Myofibroblast|myofibroblastic]] proliferation and prominent activity distinguish AIP from the other types of idiopathic interstitial pneumonia.
**[[Pneumocyte|Type II pneumocyte]] [[hyperplasia]] with cytologic [[atypia]] and [[Respiratory epithelium|bronchiolar]] [[Squamous epithelium|squamous]] [[metaplasia]] is present.
**[[Pneumocyte|Type II pneumocyte]] [[hyperplasia]] with cytologic [[atypia]] and [[Respiratory epithelium|bronchiolar]] [[Squamous epithelium|squamous]] [[metaplasia]] is present.

Revision as of 20:56, 20 March 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chandrakala Yannam, MD [2]

Overview

Acute interstitial pneumonitis show histopathologic appearance of diffuse alveolar damage, that is idiopathic. On gross examination, lungs appear firm, heavy and have a dark red or beefy appearance and show irregular areas of consolidation and fibrosis.


Pathophysiology

Pathogenesis

Gross Pathology

Microscopic Pathology

References

  1. Nur Urer H, Ersoy G, Yılmazbayhan ED (2012). "Diffuse alveolar damage of the lungs in forensic autopsies: assessment of histopathological stages and causes of death". ScientificWorldJournal. 2012: 657316. doi:10.1100/2012/657316. PMC 3458269. PMID 23028252.
  2. Kang D, Nakayama T, Togashi M, Yamamoto M, Takahashi M, Kunugi S, Ishizaki M, Fukuda Y (November 2009). "Two forms of diffuse alveolar damage in the lungs of patients with acute respiratory distress syndrome". Hum. Pathol. 40 (11): 1618–27. doi:10.1016/j.humpath.2009.04.019. PMID 19647854.
  3. Tomashefski JF (September 2000). "Pulmonary pathology of acute respiratory distress syndrome". Clin. Chest Med. 21 (3): 435–66. PMID 11019719.
  4. Mukhopadhyay S, Parambil JG (October 2012). "Acute interstitial pneumonia (AIP): relationship to Hamman-Rich syndrome, diffuse alveolar damage (DAD), and acute respiratory distress syndrome (ARDS)". Semin Respir Crit Care Med. 33 (5): 476–85. doi:10.1055/s-0032-1325158. PMID 23001802.
  5. Bonaccorsi A, Cancellieri A, Chilosi M, Trisolini R, Boaron M, Crimi N, Poletti V (January 2003). "Acute interstitial pneumonia: report of a series". Eur. Respir. J. 21 (1): 187–91. PMID 12570127.

Template:WH Template:WS

References

Template:WH Template:WS